Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Harrow Inc (HROW)

Harrow Inc (HROW)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Harrow Inc 1A Burton Hills Blvd. Suite 200 Nashville TN 37215 USA

www.harrow.com Employees: 382 P: 615-733-4730

Sector:

Medical

Description:

Harrow Inc. is an eyecare pharmaceutical company. It engaged in the discovery, development, and commercialization of innovative ophthalmic pharmaceutical products principally for the U.S. market. Harrow Inc., formerly known as Harrow Health Inc., is based in NASHVILLE, Tenn.

Key Statistics

Overview:

Market Capitalization, $K 1,767,035
Enterprise Value, $K 1,939,325
Shares Outstanding, K 37,037
Float, K 31,422
% Float 84.84%
Short Interest, K 5,549
Short Float 14.98%
Days to Cover 8.13
Short Volume Ratio 0.64
% of Insider Shareholders 15.16%
% of Institutional Shareholders 72.76%

Financials:

Annual Sales, $ 199,610 K
Annual Net Income, $ -17,480 K
Last Quarter Sales, $ 71,640 K
Last Quarter Net Income, $ 1,020 K
EBIT, $ 28,080 K
EBITDA, $ 46,820 K

Growth:

1-Year Return 50.61%
3-Year Return 166.83%
5-Year Return 436.07%
5-Year Revenue Growth 290.09%
5-Year Earnings Growth -34.48%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.33 on 11/10/25
Next Earnings Date 03/26/26
Earnings Per Share ttm 0.44
EPS Growth vs. Prev Qtr 37.50%
EPS Growth vs. Prev Year 375.00%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-5 on 02/08/13

HROW Ratios

Ratio
Price/Earnings ttm 107.86
Price/Earnings forward 36.56
Price/Earnings to Growth N/A
Return-on-Equity % 28.71%
Return-on-Assets % 4.35%
Profit Margin % -8.76%
Debt/Equity 5.21
Price/Sales 6.94
Price/Cash Flow 347.08
Price/Book 37.64
Book Value/Share 1.26
Interest Coverage -0.24
60-Month Beta 0.07
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar